Dr Gareth Cave, Founder and Director of Pharm2Farm Limited Interview artwork
Share Talk

Dr Gareth Cave, Founder and Director of Pharm2Farm Limited Interview

  • 16:57
  • November 17th 2020

Nov 17, 8:10 PM


Facebook

Twitter

 Playlist

 Headliner

 Embed

Pharm2Farm Limited ("P2F") anti-viral surgical mask project


P2F has developed a coating for textiles which incorporates its proprietary nanoparticles to give textiles long-lasting virucidal properties. The first application of this technology has been to coat a fabric layer in surgical masks and produce a certified antiviral (including COVID-19 and Influenza) mask for use by both healthcare professionals and the public.


Dr Gareth Caveis a University Lecturer at Nottingham Trent University, who has invented a face mask that is "more than 90% effective at killing coronavirus.

The anti-viral face-covering features a fluid-repellent outer layer which reduces the inhalation of droplets that carry Covid-19.

There is also a copper lining embedded in the mask which releases ions which kill the virus if they come into contact with it.

Tests have shown that the masks kills more than 90% of flu and coronavirus infections.

https://www.share-talk.com/dr-gareth-cave-founder-and-director-of-pharm2farm-limited-interview/

Share Talk

Designed for Private - Retail Investors, bloggers, brokers, PR, listed companies to communicate on one information portal. Please note we are an unregulated website and will never give out advice. We are here to make investing a level playing field.

Support Us